In Vitro Evaluation of Extended Release HPMC Matrix Tablets and Correlation with In Vivo Data
Lek Pharmaceuticals d.d., Sandoz Development Center Slovenia, Verovškova 57, SI-1526 Ljubljana, Slovenia
*
Author to whom correspondence should be addressed.
Sci. Pharm. 2010, 78(3), 611; https://doi.org/10.3797/scipharm.cespt.8.PDD22
Submission received: 12 July 2010
/
Accepted: 12 July 2010
/
Published: 12 July 2010
Abstract
Due to complexity and interplay of variable gastrointestinal conditions with matrix tablets which are predominantly erosion controlled it is often difficult to predict in vivo release profile [1]. [...]
Share and Cite
MDPI and ACS Style
KLANČAR, U.; LEGEN, I.; HORVAT, M. In Vitro Evaluation of Extended Release HPMC Matrix Tablets and Correlation with In Vivo Data. Sci. Pharm. 2010, 78, 611. https://doi.org/10.3797/scipharm.cespt.8.PDD22
AMA Style
KLANČAR U, LEGEN I, HORVAT M. In Vitro Evaluation of Extended Release HPMC Matrix Tablets and Correlation with In Vivo Data. Scientia Pharmaceutica. 2010; 78(3):611. https://doi.org/10.3797/scipharm.cespt.8.PDD22
Chicago/Turabian StyleKLANČAR, U., I. LEGEN, and M. HORVAT. 2010. "In Vitro Evaluation of Extended Release HPMC Matrix Tablets and Correlation with In Vivo Data" Scientia Pharmaceutica 78, no. 3: 611. https://doi.org/10.3797/scipharm.cespt.8.PDD22
